IBSA Pipeline AGs - Pain/Inflammation
Pain and Inflammation
ApprovedActive
Key Facts
About YARAL Pharma
YARAL Pharma is a private, commercial-stage generics company founded in 2019 and headquartered in San Diego, California. As the U.S. arm of IBSA, it leverages its parent company's manufacturing expertise and pipeline to commercialize authorized generics in therapeutic areas like pain and endocrinology, with plans to expand into dermatology and reproductive medicine. The company's strategy centers on ensuring supply continuity, forming strategic partnerships, and providing smarter solutions within the generic drug market to enhance healthcare outcomes.
View full company profileOther Pain and Inflammation Drugs
| Drug | Company | Phase |
|---|---|---|
| Pain & Inflammation Therapy | Electrome | Pre-market |